These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31686116)

  • 1. [Inborn errors of high-density lipoprotein metabolism].
    von Eckardstein A
    Internist (Berl); 2019 Dec; 60(12):1311-1318. PubMed ID: 31686116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein distribution and serum concentrations of 7α-hydroxy-4-cholesten-3-one and bile acids: effects of monogenic disturbances in high-density lipoprotein metabolism.
    Steiner C; Holleboom AG; Karuna R; Motazacker MM; Kuivenhoven JA; Frikke-Schmidt R; Tybjaerg-Hansen A; Rohrer L; Rentsch KM; Eckardstein Av
    Clin Sci (Lond); 2012 Apr; 122(8):385-96. PubMed ID: 22010943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel homozygous frameshift mutation in the APOA1 gene associated with marked high-density lipoprotein deficiency.
    Takeda T; Ide T; Okuda D; Kuroda M; Asada S; Kirinashizawa M; Yamamoto M; Miyoshi J; Yokote K; Mizutani N
    J Clin Lipidol; 2022; 16(4):423-433. PubMed ID: 35778257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of antioxidant/anti-inflammatory properties and apoA-I-containing subpopulations of HDL from family subjects with monogenic low HDL disorders.
    Daniil G; Phedonos AA; Holleboom AG; Motazacker MM; Argyri L; Kuivenhoven JA; Chroni A
    Clin Chim Acta; 2011 Jun; 412(13-14):1213-20. PubMed ID: 21420943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and secondary causes of severe HDL deficiency and cardiovascular disease.
    Geller AS; Polisecki EY; Diffenderfer MR; Asztalos BF; Karathanasis SK; Hegele RA; Schaefer EJ
    J Lipid Res; 2018 Dec; 59(12):2421-2435. PubMed ID: 30333156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased risk of premature coronary artery disease in Egyptians with ABCA1 (R219K), CETP (TaqIB), and LCAT (4886C/T) genes polymorphism.
    Abd El-Aziz TA; Mohamed RH; Hagrass HA
    J Clin Lipidol; 2014; 8(4):381-9. PubMed ID: 25110219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels of 27-hydroxycholesterol in humans and mice with monogenic disturbances of high density lipoprotein metabolism.
    Karuna R; Holleboom AG; Motazacker MM; Kuivenhoven JA; Frikke-Schmidt R; Tybjaerg-Hansen A; Georgopoulos S; van Eck M; van Berkel TJ; von Eckardstein A; Rentsch KM
    Atherosclerosis; 2011 Feb; 214(2):448-55. PubMed ID: 21130455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tangier disease: epidemiology, pathophysiology, and management.
    Puntoni M; Sbrana F; Bigazzi F; Sampietro T
    Am J Cardiovasc Drugs; 2012 Oct; 12(5):303-11. PubMed ID: 22913675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased risk of coronary artery disease in Caucasians with extremely low HDL cholesterol due to mutations in ABCA1, APOA1, and LCAT.
    Tietjen I; Hovingh GK; Singaraja R; Radomski C; McEwen J; Chan E; Mattice M; Legendre A; Kastelein JJ; Hayden MR
    Biochim Biophys Acta; 2012 Mar; 1821(3):416-24. PubMed ID: 21875686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of four novel genes contributing to familial elevated plasma HDL cholesterol in humans.
    Singaraja RR; Tietjen I; Hovingh GK; Franchini PL; Radomski C; Wong K; vanHeek M; Stylianou IM; Lin L; Wang L; Mitnaul L; Hubbard B; Winther M; Mattice M; Legendre A; Sherrington R; Kastelein JJ; Akinsanya K; Plump A; Hayden MR
    J Lipid Res; 2014 Aug; 55(8):1693-701. PubMed ID: 24891332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL.
    Zannis VI; Chroni A; Krieger M
    J Mol Med (Berl); 2006 Apr; 84(4):276-94. PubMed ID: 16501936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naturally occurring and bioengineered apoA-I mutations that inhibit the conversion of discoidal to spherical HDL: the abnormal HDL phenotypes can be corrected by treatment with LCAT.
    Koukos G; Chroni A; Duka A; Kardassis D; Zannis VI
    Biochem J; 2007 Aug; 406(1):167-74. PubMed ID: 17506726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein A-I in mouse cerebrospinal fluid derives from the liver and intestine via plasma high-density lipoproteins assembled by ABCA1 and LCAT.
    Tsujita M; Vaisman B; Chengyu L; Vickers KC; Okuhira KI; Braesch-Andersen S; Remaley AT
    FEBS Lett; 2021 Mar; 595(6):773-788. PubMed ID: 33020907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye disease.
    Rader DJ; Ikewaki K; Duverger N; Schmidt H; Pritchard H; Frohlich J; Clerc M; Dumon MF; Fairwell T; Zech L
    J Clin Invest; 1994 Jan; 93(1):321-30. PubMed ID: 8282802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma levels of sphingosine-1-phosphate and apolipoprotein M in patients with monogenic disorders of HDL metabolism.
    Karuna R; Park R; Othman A; Holleboom AG; Motazacker MM; Sutter I; Kuivenhoven JA; Rohrer L; Matile H; Hornemann T; Stoffel M; Rentsch KM; von Eckardstein A
    Atherosclerosis; 2011 Dec; 219(2):855-63. PubMed ID: 21944699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and functional analysis of missense mutations in the lecithin cholesterol acyltransferase gene in a Chilean patient with hypoalphalipoproteinemia.
    Tobar HE; Cataldo LR; González T; Rodríguez R; Serrano V; Arteaga A; Álvarez-Mercado A; Lagos CF; Vicuña L; Miranda JP; Pereira A; Bravo C; Aguilera CM; Eyheramendy S; Uauy R; Martínez Á; Gil Á; Francone O; Rigotti A; Santos JL
    Lipids Health Dis; 2019 Jun; 18(1):132. PubMed ID: 31164121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LCAT can rescue the abnormal phenotype produced by the natural ApoA-I mutations (Leu141Arg)Pisa and (Leu159Arg)FIN.
    Koukos G; Chroni A; Duka A; Kardassis D; Zannis VI
    Biochemistry; 2007 Sep; 46(37):10713-21. PubMed ID: 17711302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marked HDL deficiency and premature coronary heart disease.
    Schaefer EJ; Santos RD; Asztalos BF
    Curr Opin Lipidol; 2010 Aug; 21(4):289-97. PubMed ID: 20616715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inherited disorders of HDL metabolism and atherosclerosis.
    Hovingh GK; de Groot E; van der Steeg W; Boekholdt SM; Hutten BA; Kuivenhoven JA; Kastelein JJ
    Curr Opin Lipidol; 2005 Apr; 16(2):139-45. PubMed ID: 15767853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-density lipoprotein metabolism: molecular targets for new therapies for atherosclerosis.
    Kawashiri MA; Maugeais C; Rader DJ
    Curr Atheroscler Rep; 2000 Sep; 2(5):363-72. PubMed ID: 11122767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.